---
subject: 'F102'
session: 'NOVEMBER'
year: '2023'
paper: '1'
question: 'Q4'
chapters:
source_type: 'exam'
time_allocated_minutes: '21.6'
---

## QUESTION 4

A life insurer selling stand-alone conventional without-profits critical illness policies is performing data checks for its annual valuation at 31/12/2023. A summary of total sums assured in force for this business is shown below, as well as sums assured related to policy movements for calendar years (CY) 2022 and 2023. 31/12/2021 31/12/2022 31/12/2023 R millions R millions R millions Sums assured in force 2 200 2 300 2 500
CY 2022 CY 2023
R millions R millions Sums assured from new policies 550 600 Sums assured lapsed 150 75 Sums assured paid out 300 250
i. Perform 4 checks on the data provided.
[4]

ii. Comment briefly on your results.
[2]

The insurer uses a market-consistent approach for the valuation and calculates its risk-based solvency capital requirements using the Value-at-Risk (VaR) measure at a 99.5% confidence level over one year.
It calculates its free capital as the excess of the value of its assets over its solvency capital requirements and value of liabilities, calculated using a gross premium valuation method.
iii. Discuss the expected impact of the following scenarios on the insurer's liabilities, capital
requirements and free capital on 31/12/2023. a. An unexpected large increase in claim administration expenses during 2023. b. An unexpected decrease in claims in 2023 from one of the critical conditions covered, due to a new drug which reduces both the likely incidence and severity of this condition.
[6]

**[Total 12]**


